Related Experiment Video
Updated: Aug 7, 2026
Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
Published on: August 9, 2024
[Chronic inflammatory demyelinating polyradiculoneuropathy in childhood: outcomes after methylprednisolone pulse
M A Rafai1, F Moutaouakil, H El Otmani
1Service de Neurologie - Explorations Fonctionnelles, Pavillon 30, CHU Ibn Rochd, Casablanca, Maroc. mo.mi2@caramail.com
Insights
Methylprednisolone (MP) boluses offer a promising alternative treatment for childhood chronic inflammatory demyelinating polyneuropathy (CIDP). This approach showed significant clinical and electrophysiological improvements in a pediatric case study.
Area of Science:
- Pediatric Neurology
- Clinical Electrophysiology
- Rare Neuromuscular Disorders
Background:
- Childhood chronic inflammatory demyelinating polyneuropathy (CIDP) is uncommon, with treatments typically involving intravenous immunoglobulin or oral corticosteroids.
- Methylprednisolone (MP) bolus therapy is an infrequently utilized treatment option for this condition.
Observation:
- A case study involving an 8-year-old child with CIDP, presenting with recurrent lower limb weakness and gait impairment since age 3.
- Clinical, electrophysiological, and cerebrospinal fluid findings were consistent with CIDP.
- The child received eight monthly MP boluses.
Findings:
- Significant clinical improvement and positive electrophysiological changes were observed after 24 months of MP bolus treatment.
- The patient experienced a satisfactory progression in both clinical and electrophysiological parameters.
- The study highlights the effectiveness of MP boluses in managing pediatric CIDP.
Implications:
- Methylprednisolone boluses represent a viable alternative treatment for pediatric CIDP.
- Understanding the unique clinical and prognostic aspects of childhood CIDP is crucial for effective management.
- This case suggests that MP boluses can lead to good outcomes in children with CIDP.
Introduction:
Chronic inflammatory demyelinating polyneuropathy (CIDP) in children is relatively rare and treatment is based primarily on intravenous immunoglobulins or oral corticosteroids. Boluses of methylprednisolone (MP) are a seldom used alternative.
Case Report:
We report the case of an 8-year-old child, first presented at the age of 3 years, with recurring episodes of functional impotence of both lower limbs and walking impairment, partially reversible without treatment. Clinical, progressive, and electrophysiological data and the analysis of the cerebrospinal fluid were compatible with CIDP. MP boluses were administered: after a total eight monthly boluses, very satisfactory progression on the clinical and electrophysiological fronts was noted after 24 months.
Conclusion:
Childhood CIDP presents clinical, electrophysiological, progressive, and prognostic particularities, they recur readily and the outcome is good. Boluses of methylprednisolone are an alternative to the treatment of these neuropathies in childhood.
